IDEAYA Biosciences (NASDAQ: IDYA) reported Q2 EPS of ($1.22), $0.16 worse than the analyst estimate of ($1.06). Revenue for the quarter came in at $8.86 million versus the consensus estimate of $7.99 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.